Reference
Bartsch SM, et al. Is Fidaxomicin worth the cost? An economic analysis. Clinical Infectious Diseases : 23 May 2013. Available from: URL: http://dx.doi.org/10.1093/cid/cit346
Rights and permissions
About this article
Cite this article
Fidaxomicin for CDI not cost effective at current cost. PharmacoEcon Outcomes News 680, 11 (2013). https://doi.org/10.1007/s40274-013-0479-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0479-2